{
    "Trade/Device Name(s)": [
        "EliA Celikey IgG"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K062583",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041173"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MVM"
    ],
    "Summary Letter Date": "December 26, 2006",
    "Summary Letter Received Date": "September 6, 2006",
    "Submission Date": "August 31, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple Antibodies Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies to tissue transglutaminase (tTG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP 100",
        "ImmunoCAP 250"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence Immunoassay"
    ],
    "Methodologies": [
        "Non-competitive solid phase EIA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for EliA Celikey IgG fluorescence immunoassay for semi-quantitative measurement of IgG antibodies to tissue transglutaminase as aid in celiac disease diagnosis",
    "Indications for Use Summary": "In vitro semi-quantitative measurement of IgG antibodies to tissue transglutaminase in human serum and plasma, as an aid in the clinical diagnosis of patients with celiac disease, for use on ImmunoCAP 100/250",
    "fda_folder": "Immunology"
}